MC-Val-Cit-PAB-clindamycin

MC-Val-Cit-PAB-clindamycin is a agent-linker conjugate for ADC with potent antitumor activity by using clindamycin (a protein synthesis inhibitor), linked via the ADC linker MC-Val-Cit-PAB.

Product Specifications

CAS Number

[1639793-13-7]

UNSPSC

12352203

Target

Drug-Linker Conjugates for ADC

Type

ADC Related

Related Pathways

Antibody-drug Conjugate/ADC Related

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/mc-val-cit-pab-clindamycin.html

Purity

99.99

Solubility

DMSO : 110 mg/mL (ultrasonic)

Smiles

C[C@H](Cl)[C@@]([C@@]1([H])O[C@@H]([C@H](O)[C@@H](O)[C@H]1O)SC)([H])NC([C@H]2[N+](C)(C[C@H](CCC)C2)CC3=CC=C(NC([C@H](CCCNC(N)=O)NC([C@H](C(C)C)NC(CCCCCN4C(C=CC4=O)=O)=O)=O)=O)C=C3)=O.[Cl-]

Molecular Formula

C46H72Cl2N8O11S

Molecular Weight

1016.08

References & Citations

[1]Staben LR, et al. Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates. Nat Chem. 2016 Dec;8 (12) :1112-1119.